AzTrials
AzTrials

DepressionNCT06393322

Evaluate the Usefulness of Mental Health e-Learning

A study testing Depression e-Learning A, Depression e-Learning B and Anxiety e-Learning A in people with Depression and Anxiety, run by McMaster University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this proposal, the investigators plan to study the impact of In this proposal, we plan to study the impact of e-learning on mental health literacy and stigma related to anxiety and depression. Read more about this study

Who is it for?
Ages 45 years and olderHealthy volunteers can take part
Conditions the study is for
Depression, Anxiety
What is being tested?
Depression e-Learning A, Depression e-Learning B and Anxiety e-Learning A
Could I receive a placebo?
No, everyone receives an active treatment
How many people
125 participants
Where
1 siteCanada
Study dates
6 Aug 2024to 30 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Live in Canada
  • 45 years of age and over
  • Good command of the English language
  • Access to email and high speed internet
  • Comfortable using email and internet

Who cannot join

  • Lives outside of Canada
  • Not 45 years of age or over
  • Does not speak English,
  • Does not have access to email or high speed internet
  • Is not comfortable using email of internet

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • McMaster University

    Hamilton, Ontario, L8S4L8

Other trials in Canada

About this study

Official title: Randomized Trial to Evaluate the Usefulness of Mental Health e-Learning

In this proposal, the investigators plan to study the impact of In this proposal, we plan to study the impact of e-learning on mental health literacy and stigma related to anxiety and depression. Participants will be randomized to one of four groups - Depression e-Learning A, Depression e-Learning B, Anxiety e-Learning A, and Anxiety e-Learning B. All participants will be given access to all e-learning at the conclusion of the study.

Conditions
Depression, Anxiety
Being tested
Depression e-Learning A, Depression e-Learning B, Anxiety e-Learning A, Anxiety e-Learning B
Keywords
Depression, Mental Health, Mental Health Literacy, e-Learning, Knowledge, Stigma, Randomized Controlled Trial
Medical subject headings
Depression, Anxiety Disorders, Psychological Well-Being, Social Stigma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Depression e-Learning AOther

    Participants in Depression e-Learning A will be provided e-learning about depression, consisting of following components:

    1. One multimedia e-learning lesson on depression;
    2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
    3. One multimedia e-learning lesson on depression; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
  • Depression e-Learning BOther

    Participants in Depression e-Learning B will be provided e-learning about depression, consisting of following components:

    1. One multimedia e-learning lesson on depression;
    2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
    3. One multimedia e-learning lesson on depression; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
  • Anxiety e-Learning AOther

    Participants in Anxiety e-Learning A will be provided e-learning about anxiety, consisting of following components:

    1. One multimedia e-learning lesson on anxiety;
    2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
  • Anxiety e-Learning BOther

    Participants in Anxiety e-Learning B will be provided e-learning about anxiety, consisting of following components:

    1. One multimedia e-learning lesson on anxiety;
    2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
Study groups in NCT06393322
Study groupRoleWhat they receive
Depression e-Learning AExperimentalNot described
Receives: Other: Depression e-Learning A
Anxiety e-Learning AExperimentalNot described
Receives: Other: Anxiety e-Learning A
Depression e-Learning BExperimentalNot described
Receives: Other: Depression e-Learning B
Anxiety e-Learning BExperimentalNot described
Receives: Other: Anxiety e-Learning B

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in the Depression Literacy Questionnaire

    The Depression Literacy Questionnaire assesses mental health literacy specific to depression. The questionnaire consists of 22 items which are true or false. Respondents can answer each item with one of three options - true, false, or I don't know. Each correct response receives one point. Higher scores indicate higher depression literacy.

    Measured: 0, 2, 4 weeks

  2. Change from baseline in the Anxiety Literacy Questionnaire

    The Anxiety Literacy Questionnaire assesses mental health literacy specific to anxiety. The questionnaire consists of 22 items which are true or false. Respondents can answer each item with one of three options - true, false, or I don't know. Each correct response receives one point. Higher scores indicate higher depression literacy.

    Measured: 0, 2, 4 weeks

Secondary outcomes (3)
  1. Change from baseline in the Depression Stigma Scale

    The Depression Stigma Scale is a 9-item assessment designed to measure stigma associated with depression with two subscales: personal and perceived. The Personal Stigma Subscale measures stigma in the respondents' own attitudes towards depression by asking them to indicate how strongly they personally agree with nine statements about depression. The Perceived Stigma Subscale measures the respondent's perception about the attitudes of others towards depression by asking them to indicate what they think most other people believe about the same nine statements. Responses to each item are measured on a five-point scale (ranging from zero 'strongly disagree' to four 'strongly agree'). Higher scores indicate higher levels of depression stigma.

    Measured: 0, 2, 4 weeks

  2. Change from baseline in the Generalized Anxiety Stigma Scale

    The Generalised Anxiety Stigma Scale is analogous, but designed to measure stigma associated with anxiety disorders. It has two subscales: personal and perceived. The Personal Stigma Subscale measures stigma in the respondents' own attitudes towards anxiety disorders by asking them to indicate how strongly they personally agree with 10 statements about anxiety disorders. The Perceived Stigma Subscale measures the respondent's perception about the attitudes of others towards anxiety disorders by asking them to indicate what they think most other people believe about the same 10 statements. Responses to each item are measured on a five-point scale (ranging from zero 'strongly disagree' to four 'strongly agree'). Higher scores indicate higher levels of anxiety stigma.

    Measured: 0, 2, 4 weeks

  3. Participant satisfaction

    A custom satisfaction questionnaire data adapted from the Information Assessment Method For All (IAM4all) will be collected and saved to assess satisfaction with the intervention.

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 May 2024
  2. Study start6 Aug 2024
  3. Primary completion12 Sep 2024
  4. Study completion30 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
125 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06393322
Sponsor's protocol ID
Levinson_AFP
Status last verified
Jul 2025
First submitted
26 Apr 2024
Last updated
30 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Depression e-Learning A, Depression e-Learning B and Anxiety e-Learning A in people with Depression and Anxiety, run by McMaster University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in the Depression Literacy Questionnaire (time frame: 0, 2, 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in